Vascular News and Research

RSS

WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events

Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study was initiated at Colorado Heart & Vascular, P.C. in Denver and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.

30 Jul 2011

Study shows fall in blood pressure during dialysis for patients increases risk of blood clotting

A sudden drop in blood pressure while undergoing dialysis has long vexed many kidney patients. Side effects associated with this situation over the long term range from stroke to seizure to heart damage to death.

30 Jul 2011

High fructose corn syrup consumption may promote heart disease

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that adults who consumed high fructose corn syrup for two weeks as 25 percent of their daily calorie requirement had increased blood levels of cholesterol and triglycerides, which have been shown to be indicators of increased risk for heart disease.

29 Jul 2011

AccuVein announces $22.5M Series B financing

AccuVein Inc., a global leader in medical imaging technology and the creator of the AV300, the world's first hand-held, non-contact vein illumination device, announced today that it has secured $22.5 million in a Series B financing.

29 Jul 2011

Natural recycling system, PPAR agonists can help protect children with heart defects

Children born with heart defects that pummel their lungs with up to three times the normal blood volume quickly find their lungs in jeopardy as well.

28 Jul 2011

VDF's annual meeting to discuss latest information in vascular disease

The Vascular Disease Foundation (VDF) is pleased to announce that Thomas R. Frieden, MD, MPH, Director, Centers for Disease Control and Prevention will be the keynote speaker at its annual meeting, "Current Issues in Vascular Disease" September 14-15 in McLean, VA.

28 Jul 2011

Hoag signs license and implementation agreement for Unibased ForSite2020 RMS software

Unibased Systems Architecture, Inc. announced today that Hoag Memorial Hospital Presbyterian (Hoag) has signed an agreement for the license and implementation of the Unibased ForSite2020 Resource Management System (RMS) software application suite, including the POCET and CASH physician and consumer portals.

27 Jul 2011

Teleflex second quarter net revenues increase 9.2% to $391.3 million

Teleflex Incorporated today announced financial results for the second quarter and six months ended June 26, 2011.

27 Jul 2011

All football players do not get chronic traumatic encephalopathy

Preliminary results from the first four brains donated to the Canadian Sports Concussion Project at the Krembil Neuroscience Centre, TorontoWesternHospital, reveal that two of the four former Canadian Football League (CFL) players suffered from a brain disease known as Chronic Traumatic Encephalopathy (CTE), while two did not show signs of CTE.

27 Jul 2011

Cipher net revenue decreases to $0.7 million for Q2 2011

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three and six months ended June 30, 2011.

26 Jul 2011

Substances found in cigarette smoke damage blood vessels' endothelial cells

A research term headed by David Bernhard from the University Department of Surgery at the Medical University of Vienna has found out that substances found in cigarette smoke lead to blood vessels' endothelial cells constantly digesting themselves.

26 Jul 2011

Covidien third quarter net sales increase 14% to $2.93 billion

Covidien plc today reported results for the third quarter of fiscal 2011. Net sales of $2.93 billion increased 14% from the $2.56 billion reported in the third quarter a year ago.

26 Jul 2011

Foot care tips for diabetes patients

With the peak of summer now upon us, many of us will take time to kick off the shoes and take a walk on the beach or maybe on a grassy field in the local park. Some may even hop into a river or creek to cool off. No worries, right? Well, for some people, relaxing barefoot comes with some concern. Specifically, those with diabetes need to pay close attention to their feet.

26 Jul 2011

Enrollment commences in Lutonix LEVANT 2 drug-coated balloon IDE trial for PAD

Lutonix today announced the first patient enrolled in the LEVANT 2 clinical trial, a global, multicenter, randomized trial evaluating the safety and efficacy of the Moxy™ Drug Coated Balloon compared to a standard angioplasty balloon for the treatment of peripheral arterial disease (PAD). The first case was performed at St. John's Hospital in Springfield, IL by Dr. Jeff Goldstein.

25 Jul 2011

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.

25 Jul 2011

Global peripheral vascular devices market to reach $5.3B by 2017

The global peripheral vascular devices market is forecast to increase from $4.3 billion in 2010 to $5.3 billion by 2017, according to a new report available on companiesandmarkets.com.

22 Jul 2011

Michigan Cardiovascular Institute performs first Astron Pulsar stent procedure in the U.S.

BIOTRONIK announced today that the first endovascular procedure was completed in the BIOFLEX-I clinical trial—a trial set to evaluate the safety and performance of the Astron and Astron Pulsar self-expanding peripheral stents.

22 Jul 2011

Montifiore's surgeons receive certification training for implanting total artificial heart

A surgical team from the Montefiore Einstein Center for Heart and Vascular Care recently received certification training for implanting the SynCardia Total Artificial Heart, a replacement heart implanted in patients at risk of imminent death from heart failure.

22 Jul 2011

Enrollment complete in Sapheon's clinical study of saphenous vein reflux disease treatment

Sapheon Inc. announced successful enrollment in a 30-patient, prospective, single-arm clinical study of the Sapheon Closure System — a single-use, minimally invasive approach to the treatment of saphenous vein reflux disease.

22 Jul 2011

BioMedix receives U.S. patent titled, 'System and Method for Testing for Cardiovascular Disease'

BioMedix, a leader in providing integrated Health Information Technology (HIT) products and services, has been awarded a U.S. Patent recognizing its innovative solutions and methods for detecting and managing cardiovascular disease.

22 Jul 2011

Vascular News and Research

WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events

Study shows fall in blood pressure during dialysis for patients increases risk of blood clotting

High fructose corn syrup consumption may promote heart disease

AccuVein announces $22.5M Series B financing

Natural recycling system, PPAR agonists can help protect children with heart defects

VDF's annual meeting to discuss latest information in vascular disease

Hoag signs license and implementation agreement for Unibased ForSite2020 RMS software

Teleflex second quarter net revenues increase 9.2% to $391.3 million

All football players do not get chronic traumatic encephalopathy

Cipher net revenue decreases to $0.7 million for Q2 2011

Substances found in cigarette smoke damage blood vessels' endothelial cells

Covidien third quarter net sales increase 14% to $2.93 billion

Foot care tips for diabetes patients

Enrollment commences in Lutonix LEVANT 2 drug-coated balloon IDE trial for PAD

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Global peripheral vascular devices market to reach $5.3B by 2017

Michigan Cardiovascular Institute performs first Astron Pulsar stent procedure in the U.S.

Montifiore's surgeons receive certification training for implanting total artificial heart

Enrollment complete in Sapheon's clinical study of saphenous vein reflux disease treatment

BioMedix receives U.S. patent titled, 'System and Method for Testing for Cardiovascular Disease'

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News